APA (7th ed.) Citation

LEUNG ONG, K., JANUSZEWSKI, A. S., FRANCIS, H., MANGANI, A. S. O., O'CONNELL, R. L., JENKINS, A., & KEECH, A. C. (2024). 321-OR: Haptoglobin (Hp) Levels and Phenotype Are Unrelated to Severe Retinopathy in Type 2 Diabetes, but Lower Hp Reductions by Fenofibrate Are Associated with Greater Retinopathy Benefit—A FIELD Trial Study. Diabetes (New York, N.Y.), 73(Supplement_1), 1. https://doi.org/10.2337/db24-321-OR

Chicago Style (17th ed.) Citation

LEUNG ONG, KWOK, ANDRZEJ S. JANUSZEWSKI, HABIB FRANCIS, ABUBAKAR SIDDIQ O. MANGANI, RACHEL L. O'CONNELL, ALICIA JENKINS, and ANTHONY C. KEECH. "321-OR: Haptoglobin (Hp) Levels and Phenotype Are Unrelated to Severe Retinopathy in Type 2 Diabetes, but Lower Hp Reductions by Fenofibrate Are Associated with Greater Retinopathy Benefit—A FIELD Trial Study." Diabetes (New York, N.Y.) 73, no. Supplement_1 (2024): 1. https://doi.org/10.2337/db24-321-OR.

MLA (9th ed.) Citation

LEUNG ONG, KWOK, et al. "321-OR: Haptoglobin (Hp) Levels and Phenotype Are Unrelated to Severe Retinopathy in Type 2 Diabetes, but Lower Hp Reductions by Fenofibrate Are Associated with Greater Retinopathy Benefit—A FIELD Trial Study." Diabetes (New York, N.Y.), vol. 73, no. Supplement_1, 2024, p. 1, https://doi.org/10.2337/db24-321-OR.